NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders

Gain-of-function mutations of NaV1.7 have been shown to produce two distinct disorders: NaV1.7 mutations that enhance activation produce inherited erythromelalgia (IEM), characterized by burning pain in the extremities; NaV1.7 mutations that impair inactivation produce a different, nonoverlapping syndrome, paroxysmal extreme pain disorder (PEPD), characterized by rectal, periocular, and perimandibular pain. Here we report a novel NaV1.7 mutation associated with a mixed clinical phenotype with characteristics of IEM and PEPD, with an alanine 1632 substitution by glutamate (A1632E) in domain IV S4–S5 linker. Patch-clamp analysis shows that A1632E produces changes in channel function seen in both IEM and PEPD mutations: A1632E hyperpolarizes (−7 mV) the voltage dependence of activation, slows deactivation, and enhances ramp responses, as observed in NaV1.7 mutations that produce IEM. A1632E depolarizes (+17mV) the voltage dependence of fast inactivation, slows fast inactivation, and prevents full inactivation, resulting in persistent inward currents similar to PEPD mutations. Using current clamp, we show that A1632E renders dorsal root ganglion (DRG) and trigeminal ganglion neurons hyperexcitable. These results demonstrate a NaV1.7 mutant with biophysical characteristics common to PEPD (impaired fast inactivation) and IEM (hyperpolarized activation, slow deactivation, and enhanced ramp currents) associated with a clinical phenotype with characteristics of both IEM and PEPD and show that this mutation renders DRG and trigeminal ganglion neurons hyperexcitable. These observations indicate that IEM and PEPD mutants are part of a physiological continuum that can produce a continuum of clinical phenotypes.

[1]  S. Priori,et al.  Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients , 2007, Circulation.

[2]  Frank Lehmann-Horn,et al.  Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita , 1998, Pflügers Archiv.

[3]  W. Catterall,et al.  A Critical Role for the S4-S5 Intracellular Loop in Domain IV of the Sodium Channel α-Subunit in Fast Inactivation* , 1998, The Journal of Biological Chemistry.

[4]  K. Wong,et al.  A Novel Tetrodotoxin-sensitive, Voltage-gated Sodium Channel Expressed in Rat and Human Dorsal Root Ganglia* , 1997, The Journal of Biological Chemistry.

[5]  Chris I. De Zeeuw,et al.  GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei , 1999, The Journal of Neuroscience.

[6]  W. Kress,et al.  A large german kindred with cold‐aggravated myotonia and a heterozygous A1481D mutation in the SCN4A gene , 2007, Muscle & nerve.

[7]  N. Chehab,et al.  Glutamine Substitution at Alanine1649 in the S4–S5 Cytoplasmic Loop of Domain 4 Removes the Voltage Sensitivity of Fast Inactivation in the Human Heart Sodium Channel , 1998, The Journal of general physiology.

[8]  B. Ding,et al.  Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia , 2004, Journal of Medical Genetics.

[9]  A. M. Rush,et al.  Sporadic onset of erythermalgia: A gain‐of‐function mutation in Nav1.7 , 2006, Annals of neurology.

[10]  S. Dib-Hajj,et al.  Size Matters: Erythromelalgia Mutation S241T in Nav1.7 Alters Channel Gating* , 2006, Journal of Biological Chemistry.

[11]  J. Drenth,et al.  Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. , 2005, Archives of neurology.

[12]  S. Dib-Hajj,et al.  NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Dib-Hajj,et al.  Sodium channel α-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): Different expression patterns in developing rat nervous system , 1997 .

[14]  S. Waxman.  Neurobiology: A channel sets the gain on pain , 2006, Nature.

[15]  S. Dib-Hajj,et al.  Inherited erythermalgia , 2006, Neurology.

[16]  Sulayman D. Dib-Hajj,et al.  From genes to pain: Nav1.7 and human pain disorders , 2007, Trends in Neurosciences.

[17]  Rachael K. Blackman,et al.  Nav1.7 Mutant A863P in Erythromelalgia: Effects of Altered Activation and Steady-State Inactivation on Excitability of Nociceptive Dorsal Root Ganglion Neurons , 2006, The Journal of Neuroscience.

[18]  E. Bertini,et al.  Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy , 2003, Neurology.

[19]  A. M. Rush,et al.  Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons , 2007, The Journal of physiology.

[20]  M. Dubé,et al.  Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations , 2007, Clinical genetics.

[21]  Stephen G Waxman,et al.  A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity , 2007, The Journal of physiology.

[22]  H. Lerche,et al.  Role in fast inactivation of conserved amino acids in the IV/S4-S5 loop of the human muscle Na+ channel , 1996, Neuroscience Letters.

[23]  S. Dib-Hajj,et al.  Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable , 2008, Molecular pain.

[24]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[25]  A. M. Rush,et al.  Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. , 2005, Brain : a journal of neurology.

[26]  S. Waxman,et al.  Slow Closed-State Inactivation: A Novel Mechanism Underlying Ramp Currents in Cells Expressing the hNE/PN1 Sodium Channel , 1998, The Journal of Neuroscience.

[27]  I. Thiffault,et al.  A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians , 2007, Neurology.

[28]  R. Horn,et al.  Role of an S4-S5 linker in sodium channel inactivation probed by mutagenesis and a peptide blocker , 1996, The Journal of general physiology.

[29]  R. L. Kirby,et al.  SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. , 2005, The Journal of investigative dermatology.

[30]  S. Dib-Hajj,et al.  Mutation I136V alters electrophysiological properties of the NaV1.7 channel in a family with onset of erythromelalgia in the second decade , 2008, Molecular pain.

[31]  John N. Wood,et al.  SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes , 2006, Neuron.

[32]  S. Halegoua,et al.  Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Berten Ceulemans,et al.  De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy , 2003, Human mutation.

[34]  S. Hsieh,et al.  Characterization of a familial case with primary erythromelalgia from Taiwan , 2007, Journal of Neurology.

[35]  S. Waxman,et al.  Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. , 2007, The Journal of clinical investigation.

[36]  A. L. Goldin,et al.  Interaction between the sodium channel inactivation linker and domain III S4-S5. , 1997, Biophysical journal.

[37]  James O. Jackson,et al.  Paroxysmal extreme pain disorder mutations within the D3/S4–S5 linker of Nav1.7 cause moderate destabilization of fast inactivation , 2008, The Journal of physiology.

[38]  S. Dib-Hajj,et al.  Distinct repriming and closed‐state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons , 2003, The Journal of physiology.

[39]  S G Waxman,et al.  A Novel Persistent Tetrodotoxin-Resistant Sodium Current In SNS-Null And Wild-Type Small Primary Sensory Neurons , 1999, The Journal of Neuroscience.

[40]  H. Eng,et al.  Synthesis of β-Tubulin, Actin, and Other Proteins in Axons of Sympathetic Neurons in Compartmented Cultures , 1999, The Journal of Neuroscience.

[41]  S. Dib-Hajj,et al.  Two tetrodotoxin‐resistant sodium channels in human dorsal root ganglion neurons , 1999, FEBS letters.

[42]  P. Lund,et al.  A stop codon mutation in SCN9A causes lack of pain sensation. , 2007, Human molecular genetics.

[43]  L. Djouhri,et al.  Sensory and electrophysiological properties of guinea‐pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel α subunit protein , 2003, The Journal of physiology.

[44]  S. Dib-Hajj,et al.  Sodium channel alpha-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. , 1997, Brain Research. Molecular Brain Research.

[45]  N. Klugbauer,et al.  Structure and functional expression of a new member of the tetrodotoxin‐sensitive voltage‐activated sodium channel family from human neuroendocrine cells. , 1995, The EMBO journal.

[46]  H. Lerche,et al.  Role in fast inactivation of the IV/S4–S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis , 1997, The Journal of physiology.

[47]  Sulayman D. Dib-Hajj,et al.  Electrophysiological Properties of Mutant Nav1.7 Sodium Channels in a Painful Inherited Neuropathy , 2004, The Journal of Neuroscience.